Driving Value for Pharma and Biotech Companies: Insights from Biotech Showcase 2012

In four years, the annual event went from 350 to 1,500 attendees with 858 companies participating, including 76 public companies, according to Sara Jane Demy, president of Demy-Colton Life Science Advisors and conference co-founder. The conference, which ran Jan. 9–11, gave small-cap and private biotech companies and investors a focused home during the busy J.P. Morgan Healthcare Conference. “This industry attracts really smart people who are trying to find ways to cure disease and, along the way, earn money for their investors. Their passion for finding cures and developing new therapies helps drive these companies forward even when times are challenging,” she said. They are delivering needed drugs—either on their own or in partnership with other biopharma companies. Several . . . → Read More: Driving Value for Pharma and Biotech Companies: Insights from Biotech Showcase 2012